A phase II clinical T trial of MK-0646, an insulin-like growth factor-1 receptor inhibitor (IGF-1R) in patients with metastatic well differentiated neuroendocrine tumors (NETs) Meeting Abstract
| Authors: | Reidy, D. L.; Hollywood, E.; Segal, M.; Saltz, L. |
| Abstract Title: | A phase II clinical T trial of MK-0646, an insulin-like growth factor-1 receptor inhibitor (IGF-1R) in patients with metastatic well differentiated neuroendocrine tumors (NETs) |
| Meeting Title: | 3rd Annual Meeting of the North American NeuroEndocrine Tumor Society |
| Journal Title: | Pancreas |
| Volume: | 40 |
| Issue: | 2 |
| Meeting Dates: | 2010 Oct 29-30 |
| Meeting Location: | Santa Fe, NM |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2011-03-01 |
| Start Page: | 330 |
| Language: | English |
| ACCESSION: | WOS:000287239700053 |
| PROVIDER: | wos |
| DOI: | 10.1097/MPA.0b013e31820e7892 |
| Notes: | --- - Meeting Abstract - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work